A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

Nature Medicine

Volumn 21, Issue 12, 2015, Pages 1508-1513

  Menachery, Vineet D ^a   Yount, Boyd L ^a   Debbink, Kari ^a,b   Agnihothram, Sudhakar ^c   Gralinski, Lisa E ^a   Plante, Jessica A ^a   Graham, Rachel L ^a   Scobey, Trevor ^a   Ge, Xing Yi ^d   Donaldson, Eric F ^a   Randell, Scott H ^b   Lanzavecchia, Antonio ^e   Marasco, Wayne A ^f   Shi, Zhengli Li ^d   Baric, Ralph S ^a,b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d WUHAN INSTITUTE OF VIROLOGY   (China)

^e INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; MONOCLONAL ANTIBODY; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; VIRUS ANTIBODY;

ARTICLE; BAT; BRONCHIOLE; CHINESE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG PARENCHYMA; NONHUMAN; ORTHOLOGY; PATHOGENESIS; PHAGE DISPLAY; PHYLOGENY; PRIORITY JOURNAL; REVERSE GENETICS; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; EPIDEMIC; EPITHELIUM CELL; FEMALE; IMMUNOLOGY; LUNG; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SERODIAGNOSIS; VIROLOGY; VIRULENCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CELL LINE; CHIROPTERA; EPIDEMICS; EPITHELIAL CELLS; FEMALE; HUMANS; LUNG; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PHYLOGENY; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRULENCE; VIRUS REPLICATION;

EID: 84949623850     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3985     Document Type: Article

References (27)

1. Ge, X.Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503, 535-538 (2013).
2. Yount, B. et al. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 100, 12995-13000 (2003).
3. Becker, M.M. et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl. Acad. Sci. USA 105, 19944-19949 (2008).
4. Peiris, J.S., Guan, Y. & Yuen, K.Y. Severe acute respiratory syndrome. Nat. Med. 10, S88-S97 (2004).
5. Al-Tawfiq, J.A. et al. Surveillance for emerging respiratory viruses. Lancet Infect. Dis. 14, 992-1000 (2014).
6. He, B. et al. Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China. J. Virol. 88, 7070-7082 (2014).
7. Li, F. Receptor recognition and cross-species infections of SARS coronavirus. Antiviral Res. 100, 246-254 (2013).
8. Sheahan, T. et al. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J. Virol. 82, 2274-2285 (2008).
9. Yoshikawa, T. et al. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS ONE 5, e8729 (2010).
10. Qiu, X. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47-53 (2014).
11. Sui, J. et al. Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog. 4, e1000197 (2008).
12. Sui, J. et al. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness. J. Virol. 88, 13769-13780 (2014).
13. Rockx, B. et al. Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. J. Infect. Dis. 201, 946-955 (2010).
14. Spruth, M. et al. A double-inactivated whole-virus candidate SARS coronavirus vaccine stimulates neutralizing and protective antibody responses. Vaccine 24, 652-661 (2006).
15. Bolles, M. et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J. Virol. 85, 12201-12215 (2011).
16. Siegrist, C.-A. in Vaccines 6th edn. (eds. Plotkin, S.A., Orenstein, W.A. & Offit, P.A.) 14-32 (W.B. Saunders, 2013).
17. Deming, D. et al. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med. 3, e525 (2006).
18. Graham, R.L., Donaldson, E.F. & Baric, R.S. A decade after SARS: strategies for controlling emerging coronaviruses. Nat. Rev. Microbiol. 11, 836-848 (2013).
19. Graham, R.L. & Baric, R.S. Recombination, reservoirs and the modular spike: mechanisms of coronavirus cross-species transmission. J. Virol. 84, 3134-3146 (2010).
20. Agnihothram, S. et al. A mouse model for betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. MBio 5, e00047-14 (2014).
21. Relman, D.A. Metagenomics, infectious disease diagnostics and outbreak investigations: sequence first, ask questions later? J. Am. Med. Assoc. 309, 1531-1532 (2013).
22. Kaiser, J. Moratorium on risky virology studies leaves work at 14 institutions in limbo. ScienceInsider http://news.sciencemag.org/biology/2014/11/moratorium-risky-virology-studies-leaves-work-14-institutions-limbo (2014).
23. Frieman, M. et al. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease. J. Virol. 86, 884-897 (2012).
24. Ren, W. et al. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J. Virol. 82, 1899-1907 (2008).
25. Sims, A.C. et al. Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells. J. Virol. 87, 3885-3902 (2013).
26. Fulcher, M.L., Gabriel, S., Burns, K.A., Yankaskas, J.R. & Randell, S.H. Well-differentiated human airway epithelial cell cultures. Methods Mol. Med. 107, 183-206 (2005).
27. Roberts, A. et al. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 3, e5.